tradingkey.logo

Fortrea Holdings Inc

FTRE
14.650USD
+0.850+6.16%
Close 02/06, 16:00ETQuotes delayed by 15 min
1.35BMarket Cap
LossP/E TTM

Fortrea Holdings Inc

14.650
+0.850+6.16%

More Details of Fortrea Holdings Inc Company

Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.

Fortrea Holdings Inc Info

Ticker SymbolFTRE
Company nameFortrea Holdings Inc
IPO dateJun 16, 2023
CEOThakrala (Anshul)
Number of employees15500
Security typeOrdinary Share
Fiscal year-endJun 16
Address8 Moore Drive
CityDURHAM
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code27709
Phone18774950816
Websitehttps://www.fortrea.com/
Ticker SymbolFTRE
IPO dateJun 16, 2023
CEOThakrala (Anshul)

Company Executives of Fortrea Holdings Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+62500.00%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+7282.00%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+7282.00%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+5097.00%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
+7282.00%
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Morais
Mr. Mark Morais
Chief Operating Officer and President - Clinical Services
Chief Operating Officer and President - Clinical Services
--
--
Ms. Hima B. Inguva
Ms. Hima B. Inguva
Investor Relations
Investor Relations
--
--
Ms. Erin L. Russell
Ms. Erin L. Russell
Independent Director
Independent Director
--
--
Mr. Anshul Thakrala
Mr. Anshul Thakrala
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+62500.00%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+7282.00%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+7282.00%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+5097.00%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
+7282.00%
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2021
FY2020
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
North America
332.70M
47.44%
Europe
213.20M
30.40%
Other
155.40M
22.16%
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Sat, Feb 7
Updated: Sat, Feb 7
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.71%
The Vanguard Group, Inc.
8.99%
Goldman Sachs & Company, Inc.
8.54%
Corvex Management LP
4.88%
State Street Investment Management (US)
4.41%
Other
59.47%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.71%
The Vanguard Group, Inc.
8.99%
Goldman Sachs & Company, Inc.
8.54%
Corvex Management LP
4.88%
State Street Investment Management (US)
4.41%
Other
59.47%
Shareholder Types
Shareholders
Proportion
Investment Advisor
46.19%
Hedge Fund
23.05%
Investment Advisor/Hedge Fund
18.36%
Research Firm
13.93%
Pension Fund
1.43%
Bank and Trust
1.36%
Individual Investor
0.50%
Family Office
0.33%
Holding Company
0.05%

Institutional Shareholding

Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
861
101.77M
121.97%
--
2025Q3
941
101.78M
123.79%
-128.81K
2025Q2
971
101.91M
125.96%
+8.10M
2025Q1
934
96.29M
123.92%
-15.90M
2024Q4
888
96.88M
127.14%
-3.71M
2024Q3
843
100.39M
126.92%
-3.95M
2024Q2
819
103.77M
114.37%
+7.39M
2024Q1
774
92.63M
104.75%
-1.02M
2023Q4
713
91.56M
111.23%
-6.24M
2023Q3
611
90.56M
44.21%
+51.30M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
12.67M
13.71%
-72.73K
-0.57%
Sep 30, 2025
The Vanguard Group, Inc.
8.03M
8.69%
-481.87K
-5.66%
Sep 30, 2025
Goldman Sachs & Company, Inc.
7.89M
8.54%
+148.09K
+1.91%
Sep 30, 2025
Corvex Management LP
4.51M
4.88%
--
--
Sep 30, 2025
State Street Investment Management (US)
4.07M
4.41%
-361.04K
-8.15%
Sep 30, 2025
Sessa Capital
3.99M
4.32%
--
--
Sep 30, 2025
AQR Capital Management, LLC
3.74M
4.04%
-2.78M
-42.66%
Sep 30, 2025
Fidelity Management & Research Company LLC
2.97M
3.21%
-11.70K
-0.39%
Sep 30, 2025
Charles Schwab Investment Management, Inc.
2.65M
2.87%
+863.47K
+48.25%
Sep 30, 2025
DWS Investments UK Limited
2.55M
2.76%
+921.34K
+56.67%
Sep 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Brandes US Small-Mid Cap Value ETF
1.39%
Invesco S&P Spin-Off ETF
0.97%
Invesco S&P SmallCap Health Care ETF
0.58%
Invesco S&P SmallCap 600 Revenue ETF
0.25%
Invesco S&P SmallCap 600 Pure Value ETF
0.23%
Schwab Fundamental U.S. Small Company ETF
0.17%
iShares S&P Small-Cap 600 Value ETF
0.16%
Humankind US Stock ETF
0.14%
ProShares Ultra Nasdaq Biotechnology
0.14%
State Street SPDR S&P 600 Small Cap Value ETF
0.13%
View more
Brandes US Small-Mid Cap Value ETF
Proportion1.39%
Invesco S&P Spin-Off ETF
Proportion0.97%
Invesco S&P SmallCap Health Care ETF
Proportion0.58%
Invesco S&P SmallCap 600 Revenue ETF
Proportion0.25%
Invesco S&P SmallCap 600 Pure Value ETF
Proportion0.23%
Schwab Fundamental U.S. Small Company ETF
Proportion0.17%
iShares S&P Small-Cap 600 Value ETF
Proportion0.16%
Humankind US Stock ETF
Proportion0.14%
ProShares Ultra Nasdaq Biotechnology
Proportion0.14%
State Street SPDR S&P 600 Small Cap Value ETF
Proportion0.13%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI